Katalin Kariko, who worked with colleague Drew Weissman in the Perelman School of Medicine to research mRNA, was profiled. Their findings laid the foundation for the development of the Pfizer and Moderna COVID-19 vaccines.

April 8, 2021 ・ From The New York Times